Log in

Koninklijke DSM Stock Forecast, Price & News

-0.28 (-0.71 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: $39.12
50-Day Range
MA: $39.51
52-Week Range
Now: $39.12
Volume11,370 shs
Average Volume77,492 shs
Market Capitalization$28.39 billion
P/E Ratio39.92
Dividend Yield0.96%
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and materials businesses in the Netherlands, North America, the United Kingdom, France, Germany, Switzerland, the Asia-Pacific, and internationally.. The company operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers nutrients, such as vitamins, carotenoids, nutritional lipids, and other ingredients to feed, food, pharmaceutical, and personal care industries; and food enzymes, cultures, yeast extracts, savory flavors, hydrocolloids, and other specialty ingredients for dairy, baking, beverage, and savory applications. The Materials segment provides specialty plastics for the electrical and electronics, automotive, flexible food packaging, and consumer goods industries; Dyneema, a fiber solution for protective solutions and commercial marine applications; and resins solutions for paints and industrial, and optical fiber coatings. The Innovation Center segment offers cellulosic and starch-based bio-ethanol, and bio-based succinic acids; anti-reflective coatings for solar glass; and anti-soiling coatings for use in cleaning and maintaining solar farms in desert-like conditions. This segment also produces biomedical materials and technologies that enable medical device manufacturers to enhance care across various medical specialties. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands.
Read More
Koninklijke DSM logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.04 out of 5 stars

Industry, Sector and Symbol

Industry Chemicals & allied products
Previous SymbolNASDAQ:RDSMY



Sales & Book Value

Annual Sales$10.09 billion
Cash Flow$2.18 per share
Book Value$12.09 per share


Net Income$848.96 million


Market Cap$28.39 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableNot Optionable
-0.28 (-0.71 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RDSMY News and Ratings via Email

Sign-up to receive the latest news and ratings for RDSMY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Koninklijke DSM (OTCMKTS:RDSMY) Frequently Asked Questions

How has Koninklijke DSM's stock price been impacted by COVID-19?

Koninklijke DSM's stock was trading at $27.56 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, RDSMY stock has increased by 41.9% and is now trading at $39.12.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Koninklijke DSM?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Koninklijke DSM in the last year. There are currently 2 sell ratings, 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Koninklijke DSM

When is Koninklijke DSM's next earnings date?

Koninklijke DSM is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Koninklijke DSM

How were Koninklijke DSM's earnings last quarter?

Koninklijke DSM (OTCMKTS:RDSMY) announced its quarterly earnings results on Tuesday, August, 4th. The basic materials company reported $0.29 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.31 by $0.02. The basic materials company had revenue of $2.46 billion for the quarter. Koninklijke DSM had a return on equity of 10.20% and a net margin of 6.97%.
View Koninklijke DSM's earnings history

How often does Koninklijke DSM pay dividends? What is the dividend yield for Koninklijke DSM?

Koninklijke DSM announced a Semi-Annual dividend on Tuesday, August 4th. Shareholders of record on Friday, August 14th will be paid a dividend of $0.188 per share on Friday, September 4th. The ex-dividend date of this dividend is Thursday, August 13th.
View Koninklijke DSM's dividend history

Who are some of Koninklijke DSM's key competitors?

Who are Koninklijke DSM's key executives?

Koninklijke DSM's management team includes the following people:
  • Mr. Feike Sijbesma, Chairman of the Managing Board & CEO (Age 60)
  • Ms. Geraldine Matchett, CFO & Member of the Managing Board (Age 47)
  • Mr. Dimitri de Vreeze, Member of the Managing Board (Age 52)
  • Mr. Jos Op Heij, Sr. VP of Corp. Control & Accounting and Group Controller
  • Marcus Remmers, Chief Technology Officer

What is Koninklijke DSM's stock symbol?

Koninklijke DSM trades on the OTCMKTS under the ticker symbol "RDSMY."

How do I buy shares of Koninklijke DSM?

Shares of RDSMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Koninklijke DSM's stock price today?

One share of RDSMY stock can currently be purchased for approximately $39.12.

How big of a company is Koninklijke DSM?

Koninklijke DSM has a market capitalization of $28.39 billion and generates $10.09 billion in revenue each year. The basic materials company earns $848.96 million in net income (profit) each year or $1.30 on an earnings per share basis. Koninklijke DSM employs 21,866 workers across the globe.

What is Koninklijke DSM's official website?

The official website for Koninklijke DSM is www.dsm.com.

How can I contact Koninklijke DSM?

Koninklijke DSM's mailing address is Het Overloon 1, Heerlrn P7, 6411 TE. The basic materials company can be reached via phone at 31-45-578-2864.

This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.